| Literature DB >> 19489338 |
E D Gol'dberg1, A M Dygai, V V Zhdanov, G N Zyuz'kov, N N Ermakova, T V Vetoshkina, T I Fomina, L A Ermolaeva, T Yu Dubskaya.
Abstract
We studied the mechanisms of therapeutic effects of granulocytic colony-stimulating factor in experimental diabetes mellitus. It was found that this preparation increased the number of mesenchymal precursor cells in the bone marrow and peripheral blood with subsequent increase in the content of progenitor cells in the pancreas. These results attest to mobilization of mesenchymal progenitor cells and their migration into the damaged tissue accompanied by morphofunctional recovery of the insulin-producing apparatus.Entities:
Mesh：
Substances：
Year: 2008 PMID： 19489338 DOI： 10.1007/s10517-009-0319-3
Source DB: PubMed Journal: Bull Exp Biol Med ISSN： 0007-4888 Impact factor: 0.804